Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis
- PMID: 8017896
- DOI: 10.1002/ana.410360721
Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis
Abstract
Magnetic resonance imaging (MRI) provides an objective method of evaluating multiple sclerosis clinical trials and is at least five times more sensitive to disease activity. In a recent clinical trial, MRI was also approximately twice as sensitive as clinical measurements to the treatment effect of a drug.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical